NORTHERN TRUST CORP - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 84 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$229,613
+27.6%
1,841,318
+5.4%
0.00%
Q4 2022$179,957
-21.1%
1,747,155
+16.4%
0.00%
Q3 2022$228,000
-83.7%
1,500,532
-5.6%
0.00%
Q2 2022$1,398,000
-31.1%
1,589,048
-2.8%
0.00%
Q1 2022$2,028,000
-46.8%
1,635,003
-16.3%
0.00%
-100.0%
Q4 2021$3,811,000
-30.4%
1,954,286
-2.2%
0.00%0.0%
Q3 2021$5,473,000
-16.4%
1,997,432
-3.9%
0.00%0.0%
Q2 2021$6,550,000
+1069.6%
2,079,179
+690.7%
0.00%
Q1 2021$560,000
+199.5%
262,940
+172.6%
0.00%
Q4 2020$187,000
+152.7%
96,470
-8.8%
0.00%
Q3 2020$74,000
+76.2%
105,786
+32.8%
0.00%
Q2 2020$42,000
+20.0%
79,6820.0%0.00%
Q1 2020$35,000
-27.1%
79,682
+14.4%
0.00%
Q4 2019$48,000
-36.0%
69,6420.0%0.00%
Q3 2019$75,000
+47.1%
69,6420.0%0.00%
Q2 2019$51,000
-42.7%
69,6420.0%0.00%
Q1 2019$89,000
-14.4%
69,6420.0%0.00%
Q4 2018$104,000
+173.7%
69,642
+168.6%
0.00%
Q3 2018$38,000
+5.6%
25,9280.0%0.00%
Q2 2018$36,000
+50.0%
25,9280.0%0.00%
Q1 2018$24,000
+100.0%
25,928
+137.5%
0.00%
Q4 2017$12,000
-29.4%
10,9180.0%0.00%
Q3 2017$17,000
-15.0%
10,9180.0%0.00%
Q2 2017$20,000
-4.8%
10,9180.0%0.00%
Q1 2017$21,00010,9180.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders